{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ophiopogonis Radix", "beta cell", "diabetes", "inflammation", "insulin secretion", "obesity"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32605924", "DateCompleted": {"Year": "2021", "Month": "01", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1074/jbc.RA120.014357"], "Journal": {"ISSN": "1083-351X", "JournalIssue": {"Volume": "295", "Issue": "36", "PubDate": {"Year": "2020", "Month": "Sep", "Day": "04"}}, "Title": "The Journal of biological chemistry", "ISOAbbreviation": "J Biol Chem"}, "ArticleTitle": "A polysaccharide extract from the medicinal plant Maidong inhibits the IKK-NF-\u03baB pathway and IL-1\u03b2-induced islet inflammation and increases insulin secretion.", "Pagination": {"StartPage": "12573", "EndPage": "12587", "MedlinePgn": "12573-12587"}, "Abstract": {"AbstractText": ["The herb dwarf lilyturf tuber (Maidong, <i>Ophiopogonis Radix</i>) is widely used in Chinese traditional medicine to manage diabetes and its complications. However, the role of Maidong polysaccharide extract (MPE) in pancreatic \u03b2-cell function is unclear. Here, we investigated whether MPE protects \u03b2-cell function and studied the underlying mechanisms. We treated <i>db/db</i> and high-fat diet (HFD)-induced obese mice with 800 or 400 mg/kg MPE or water for 4 weeks, followed by an oral glucose tolerance test. Pancreas and blood were collected for molecular analyses, and clonal MIN6 \u03b2-cells and primary islets from HFD-induced obese mice and normal chow diet-fed mice were used in additional analyses. <i>In vivo</i>, MPE both increased insulin secretion and reduced blood glucose in the <i>db/db</i> mice but increased only insulin secretion in the HFD-induced obese mice. MPE substantially increased the \u03b2-cell area in both models (3-fold and 2-fold, <i>p</i> < 0.01, for <i>db/db</i> and HFD mice, respectively). We observed reduced nuclear translocation of the p65 subunit of NF-\u03baB in islets of MPE-treated db/db mice, coinciding with enhanced glucose-stimulated insulin secretion (GSIS). <i>In vitro</i>, MPE potentiated GSIS and decreased interleukin 1\u03b2 (IL-1\u03b2) secretion in MIN6 \u03b2-cells. Incubation of MIN6 cells with tumor necrosis factor \u03b1 (TNF\u03b1), interferon-\u03b3, and IL-1\u03b2 amplified IL-1\u03b2 secretion and inhibited GSIS. These effects were partially reversed with MPE or the I\u03baB kinase \u03b2 inhibitor PS1145, coinciding with reduced activation of p65 and p-I\u03baB in the NF-\u03baB pathway. We conclude that MPE may have potential for therapeutic development for \u03b2-cell protection."], "CopyrightInformation": "\u00a9 2020 Mao et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Mao", "ForeName": "Dandan", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Tian", "ForeName": "Xiao Yu", "Initials": "XY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Mao", "ForeName": "Di", "Initials": "D"}, {"Identifier": ["0000-0003-0576-4707"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Hung", "ForeName": "Sze Wan", "Initials": "SW"}, {"Identifier": ["0000-0002-3928-7278"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Wang", "ForeName": "Chi Chiu", "Initials": "CC"}, {"Identifier": ["0000-0002-7409-1270"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Lau", "ForeName": "Clara Bik San", "Initials": "CBS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Lee", "ForeName": "Heung Man", "Initials": "HM"}, {"Identifier": ["0000-0002-5637-8331"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Wong", "ForeName": "Chun Kwok", "Initials": "CK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Phase 1 Clinical Trial Centre, Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Chow", "ForeName": "Elaine", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Ming", "ForeName": "Xing", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Cao", "ForeName": "Huanyi", "Initials": "H"}, {"Identifier": ["0000-0002-1227-803X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Ma", "ForeName": "Ronald C", "Initials": "RC"}, {"Identifier": ["0000-0002-6360-4608"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Microbiology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Chan", "ForeName": "Paul K S", "Initials": "PKS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Kong", "ForeName": "Alice P S", "Initials": "APS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Li", "ForeName": "Joshua J X", "Initials": "JJX"}, {"Identifier": ["0000-0001-6360-0343"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United Kingdom."}, {"Identifier": [], "Affiliation": "Lee Kong Chian School of Medicine, Nan Yang Technological University, Singapore."}], "LastName": "Rutter", "ForeName": "Guy A", "Initials": "GA"}, {"Identifier": ["0000-0003-1189-740X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Tam", "ForeName": "Wing Hung", "Initials": "WH"}, {"Identifier": ["0000-0003-1325-1194"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China jchan@cuhk.edu.hk."}, {"Identifier": [], "Affiliation": "Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Chan", "ForeName": "Juliana C N", "Initials": "JCN"}], "GrantList": [{"GrantID": "WT098424AIA", "Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"GrantID": "MR/S025618/1", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}, {"GrantID": "MR/N00275X/1", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}, {"GrantID": "MR/L020149/1", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}, {"GrantID": "MR/R022259/1", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}, {"GrantID": "MR/J0003042/1", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}, {"Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"GrantID": "212625/Z/18/Z", "Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Biol Chem", "NlmUniqueID": "2985121R", "ISSNLinking": "0021-9258"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Dietary Fats"}, {"RegistryNumber": "0", "NameOfSubstance": "IL1B protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Rela protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factor RelA"}, {"RegistryNumber": "EC 2.7.11.10", "NameOfSubstance": "I-kappa B Kinase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["adverse effects", "pharmacology"], "DescriptorName": "Dietary Fats"}, {"QualifierName": ["metabolism"], "DescriptorName": "I-kappa B Kinase"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Insulin Secretion"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Insulin-Secreting Cells"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-1beta"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism", "pathology"], "DescriptorName": "Obesity"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ophiopogon"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["genetics"], "DescriptorName": "Plant Tubers"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transcription Factor RelA"}], "CoiStatement": "Conflict of interest\u2014J. C. N. C. reported receiving research grants and/or honoraria for consultancy or giving lectures from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Serono, Merck Sharp & Dohme, Pfizer, and Sanofi. R. C. W. M. reported receiving grants and/or honoraria for consultancy or giving lectures from AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Pfizer, and Takeda. A. P. S. K. has received research grants and/or speaker honoraria from Abbott, AstraZeneca, Eli Lilly, Merck Serono, Nestle, and Novo Nordisk. E. C. reported receiving grants from Lee Powder and Sanofi. G. A. R. has received grant funding from Servier and from Sun Pharma."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "World Health Organization (2016) Global Report on Diabetes, p. 6, World Health Organization, Geneva"}, {"Citation": "Cho N. H., Shaw J. E., Karuranga S., Huang Y., da Rocha Fernandes J. D., Ohlrogge A. W., and Malanda B. (2018) IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 138, 271\u2013281 10.1016/j.diabres.2018.02.023", "ArticleIdList": ["10.1016/j.diabres.2018.02.023", "29496507"]}, {"Citation": "Tahrani A. A., Bailey C. J., Del Prato S., and Barnett A. H. (2011) Management of type 2 diabetes: new and future developments in treatment. Lancet 378, 182\u2013197 10.1016/S0140-6736(11)60207-9", "ArticleIdList": ["10.1016/S0140-6736(11)60207-9", "21705062"]}, {"Citation": "Kim J. E., Hwang I. S., Choi S. I., Lee H. R., Lee Y. J., Goo J. S., Lee H. S., Son H. J., Jang M. J., Lee S. H., Kang B. C., and Hwang D. Y. (2012) Aqueous extract of Liriope platyphylla, a traditional Chinese medicine, significantly inhibits abdominal fat accumulation and improves glucose regulation in OLETF type II diabetes model rats. Lab. Anim. Res. 28, 181\u2013191 10.5625/lar.2012.28.3.181", "ArticleIdList": ["10.5625/lar.2012.28.3.181", "PMC3469846", "23091518"]}, {"Citation": "Ding L., Li P., Lau C. B., Chan Y. W., Xu D., Fung K. P., and Su W. (2012) Mechanistic studies on the antidiabetic activity of a polysaccharide-rich extract of Radix Ophiopogonis. Phytother. Res. 26, 101\u2013105 10.1002/ptr.3505", "ArticleIdList": ["10.1002/ptr.3505", "21560174"]}, {"Citation": "Liu Y., Wan L., Xiao Z., Wang J., Wang Y., and Chen J. (2013) Antidiabetic activity of polysaccharides from tuberous root of Liriope spicata var. prolifera in KKAy mice. Evid. Based Complement. Alternat. Med. 2013, 349790 10.1155/2013/349790", "ArticleIdList": ["10.1155/2013/349790", "PMC3677662", "23762123"]}, {"Citation": "Xu J., Wang Y., Xu D. S., Ruan K. F., Feng Y., and Wang S. (2011) Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus. Int. J. Biol. Macromol. 49, 657\u2013662 10.1016/j.ijbiomac.2011.06.026", "ArticleIdList": ["10.1016/j.ijbiomac.2011.06.026", "21756932"]}, {"Citation": "Wang L. Y., Wang Y., Xu D. S., Ruan K. F., Feng Y., and Wang S. (2012) MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model. J. Ethnopharmacol. 143, 347\u2013354 10.1016/j.jep.2012.06.050", "ArticleIdList": ["10.1016/j.jep.2012.06.050", "22776833"]}, {"Citation": "Bayer, Inc. (2014) PrGLUCOBAYTM acarbose: 50 and 100 mg tablets: Product Monograph. Bayer, Inc., Mississauga, Ontario, Canada"}, {"Citation": "Ni Q., Wang J., Li E. Q., Zhao A. B., Yu B., Wang M., and Huang C. R. (2011) Study on the protective effect of the Mixture of Shengmai Powder and Danshen Decoction on the myocardium of diabetic cardiomyopathy in the rat model. Chin. J. Integr. Med. 17, 116\u2013125 10.1007/s11655-011-0639-9", "ArticleIdList": ["10.1007/s11655-011-0639-9", "21390578"]}, {"Citation": "Yabe D., and Seino Y. (2016) Type 2 diabetes via beta-cell dysfunction in east Asian people. Lancet Diabetes Endocrinol. 4, 2\u20133 10.1016/S2213-8587(15)00389-7", "ArticleIdList": ["10.1016/S2213-8587(15)00389-7", "26577717"]}, {"Citation": "Cerf M. E. (2013) Beta cell dysfunction and insulin resistance. Front. Endocrinol. (Lausanne) 4, 1\u201310 10.3389/fendo.2013.00037", "ArticleIdList": ["10.3389/fendo.2013.00037", "PMC3608918", "23542897"]}, {"Citation": "Yang H., and Li X. (2012) The role of fatty acid metabolism and lipotoxicity in pancreatic \u03b2-cell injury: identification of potential therapeutic targets. Acta Pharm. Sin. B 2, 396\u2013402 10.1016/j.apsb.2012.05.003", "ArticleIdList": ["10.1016/j.apsb.2012.05.003"]}, {"Citation": "Flannick J., Mercader J. M., Fuchsberger C., Udler M. S., Mahajan A., Wessel J., Teslovich T. M., Caulkins L., Koesterer R., Barajas-Olmos F., Blackwell T. W., Boerwinkle E., Brody J. A., Centeno-Cruz F., Chen L., et al. (2019) Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature 570, 71\u201376 10.1038/s41586-019-1231-2", "ArticleIdList": ["10.1038/s41586-019-1231-2", "PMC6699738", "31118516"]}, {"Citation": "Maedler K., Sergeev P., Ris F., Oberholzer J., Joller-Jemelka H. I., Spinas G. A., Kaiser N., Halban P. A., and Donath M. Y. (2017) Glucose-induced beta cell production of IL-1\u03b2 contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 127, 1589\u20131860 10.1172/JCI92172", "ArticleIdList": ["10.1172/JCI92172", "PMC5373884", "28368291"]}, {"Citation": "Cunha D. A., Hekerman P., Ladri\u00e8re L., Bazarra-Castro A., Ortis F., Wakeham M. C., Moore F., Rasschaert J., Cardozo A. K., Bellomo E., Overbergh L., Mathieu C., Lupi R., Hai T., Herchuelz A., et al. (2008) Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J. Cell Sci. 121, 2308\u20132318 10.1242/jcs.026062", "ArticleIdList": ["10.1242/jcs.026062", "PMC3675788", "18559892"]}, {"Citation": "Eguchi K., and Manabe I. (2013) Macrophages and islet inflammation in type 2 diabetes. Diabetes Obes. Metab. 15, 152\u2013158 10.1111/dom.12168", "ArticleIdList": ["10.1111/dom.12168", "24003932"]}, {"Citation": "B\u00f6ni-Schnetzler M., H\u00e4uselmann S. P., Dalmas E., Meier D. T., Thienel C., Traub S., Schulze F., Steiger L., Dror E., Martin P., Herrera P. L., Gabay C., and Donath M. Y. (2018) Beta cell-specific deletion of the IL-1 receptor antagonist impairs beta cell proliferation and insulin secretion. Cell Rep. 22, 1774\u20131786 10.1016/j.celrep.2018.01.063", "ArticleIdList": ["10.1016/j.celrep.2018.01.063", "29444430"]}, {"Citation": "Dinarello C. A., Simon A., and van der Meer J. W. (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11, 633\u2013652 10.1038/nrd3800", "ArticleIdList": ["10.1038/nrd3800", "PMC3644509", "22850787"]}, {"Citation": "Maedler K., Sergeev P., Ris F., Oberholzer J., Joller-Jemelka H. I., Spinas G. A., Kaiser N., Halban P. A., and Donath M. Y. (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110, 851\u2013860 10.1172/JCI200215318", "ArticleIdList": ["10.1172/JCI200215318", "PMC151125", "12235117"]}, {"Citation": "Sousa S. G., Oliveira L. A., de Aguiar Magalh\u00e3es D., de Brito T. V., Batista J. A., Pereira C. M. C., de Souza Costa M., Mazulo J. C. R., de Carvalho Filgueiras M., Vasconselos D. F. P., da Silva D. A., Barros F. C. N., Sombra V. G., Freitas A. L. P., de Paula R. C. M., et al. (2018) Chemical structure and anti-inflammatory effect of polysaccharide extracted from Morinda citrifolia Linn (Noni). Carbohydr. Polym. 197, 515\u2013523 10.1016/j.carbpol.2018.06.042", "ArticleIdList": ["10.1016/j.carbpol.2018.06.042", "30007642"]}, {"Citation": "Illuri R., Bethapudi B., Anandakumar S., Murugan S., Joseph J. A., Mundkinajeddu D., Agarwal A., and Chandrasekaran C. V. (2015) Anti-inflammatory activity of polysaccharide fraction of Curcuma longa extract (NR-INF-02). Antiinflamm. Antiallergy Agents Med. Chem. 14, 53\u201362 10.2174/1871523014666150407150533", "ArticleIdList": ["10.2174/1871523014666150407150533", "26013326"]}, {"Citation": "Gao C., Liu L., Zhou Y., Bian Z., Wang S., and Wang Y. (2019) Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease. Chin. Med. 14, 23\u201340 10.1186/s13020-019-0245-x", "ArticleIdList": ["10.1186/s13020-019-0245-x", "PMC6580650", "31236131"]}, {"Citation": "Miyazaki J., Araki K., Yamato E., Ikegami H., Asano T., Shibasaki Y., Oka Y., and Yamamura K. (1990) Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127, 126\u2013132 10.1210/endo-127-1-126", "ArticleIdList": ["10.1210/endo-127-1-126", "2163307"]}, {"Citation": "Sidarala V., and Kowluru A. (2017) The regulatory roles of mitogen-activated protein kinase (MAPK) pathways in health and diabetes: lessons learned from the pancreatic beta-cell. Recent Pat. Endocr. Metab. Immune Drug Discov. 10, 76\u201384 10.2174/1872214810666161020154905", "ArticleIdList": ["10.2174/1872214810666161020154905", "PMC6685434", "27779078"]}, {"Citation": "Huang X., Liu G., Guo J., and Su Z. (2018) The PI3K/AKT pathway in obesity and type 2 diabetes. Int. J. Biol. Sci. 14, 1483\u20131496 10.7150/ijbs.27173", "ArticleIdList": ["10.7150/ijbs.27173", "PMC6158718", "30263000"]}, {"Citation": "Greten F. R., Arkan M. C., Bollrath J., Hsu L. C., Goode J., Miething C., G\u00f6ktuna S. I., Neuenhahn M., Fierer J., Paxian S., Van Rooijen N., Xu Y., O'Cain T., Jaffee B. B., Busch D. H., et al. (2007) NF-\u03baB is a negative regulator of IL-1\u03b2 secretion as revealed by genetic and pharmacological inhibition of IKK\u03b2. Cell 130, 918\u2013931 10.1016/j.cell.2007.07.009", "ArticleIdList": ["10.1016/j.cell.2007.07.009", "PMC2134986", "17803913"]}, {"Citation": "Liu T., Zhang L., Joo D., and Sun S. C. (2017) NF-\u03baB signaling in inflammation. Signal Transduct. Target Ther. 2, 1\u201310 10.1038/sigtrans.2017.23", "ArticleIdList": ["10.1038/sigtrans.2017.23", "PMC5661633", "29158945"]}, {"Citation": "Ackermann A. M., and Gannon M. (2007) Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J. Mol. Endocrinol. 38, 193\u2013206 10.1677/JME-06-0053", "ArticleIdList": ["10.1677/JME-06-0053", "17293440"]}, {"Citation": "Yin J., Zhang H., and Ye J. (2008) Traditional Chinese medicine in treatment of metabolic syndrome. Endocr. Metab. Immune Disord. Drug Targets 8, 99\u2013111 10.2174/187153008784534330", "ArticleIdList": ["10.2174/187153008784534330", "PMC2467395", "18537696"]}, {"Citation": "Zhao H. L., Sui Y., Qiao C. F., Yip K. Y., Leung R. K., Tsui S. K., Lee H. M., Wong H. K., Zhu X., Siu J. J., He L., Guan J., Liu L. Z., Xu H. X., Tong P. C., et al. (2012) Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression. Diabetes 61, 933\u2013943 10.2337/db11-1164", "ArticleIdList": ["10.2337/db11-1164", "PMC3314348", "22396199"]}, {"Citation": "Ko C. H., Yi S., Ozaki R., Cochrane H., Chung H., Lau W., Koon C. M., Hoi S. W., Lo W., Cheng K. F., Lau C. B., Chan W. Y., Leung P. C., and Chan J. C. (2014) Healing effect of a two-herb recipe (NF3) on foot ulcers in Chinese patients with diabetes: a randomized double-blind placebo-controlled study. J. Diabetes 6, 323\u2013334 10.1111/1753-0407.12117", "ArticleIdList": ["10.1111/1753-0407.12117", "24330156"]}, {"Citation": "Hsieh H. Y., Chiu P. H., and Wang S. C. (2013) Histone modifications and traditional Chinese medicinals. BMC Complement Altern. Med. 13, 115\u2013126 10.1186/1472-6882-13-115", "ArticleIdList": ["10.1186/1472-6882-13-115", "PMC3698099", "23711355"]}, {"Citation": "Lawless M. W., O'Byrne K. J., and Gray S. G. (2009) Histone deacetylase inhibitors target diabetes via chromatin remodeling or as chemical chaperones? Curr. Diabetes Rev. 5, 201\u2013209 10.2174/157339909788920956", "ArticleIdList": ["10.2174/157339909788920956", "19689255"]}, {"Citation": "Wang P., Alvarez-Perez J. C., Felsenfeld D. P., Liu H., Sivendran S., Bender A., Kumar A., Sanchez R., Scott D. K., Garcia-Oca\u00f1a A., and Stewart A. F. (2015) A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat. Med. 21, 383\u2013388 10.1038/nm.3820", "ArticleIdList": ["10.1038/nm.3820", "PMC4690535", "25751815"]}, {"Citation": "Cernea S., and Dobreanu M. (2013) Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochem. Med. (Zagreb) 23, 266\u2013280 10.11613/bm.2013.033", "ArticleIdList": ["10.11613/bm.2013.033", "PMC3900074", "24266296"]}, {"Citation": "Jablecka A., Bogdanski P., Balcer N., Cieslewicz A., Skoluda A., and Musialik K. (2012) The effect of oral l-arginine supplementation on fasting glucose, HbA1c, nitric oxide and total antioxidant status in diabetic patients with atherosclerotic peripheral arterial disease of lower extremities. Eur. Rev. Med. Pharmacol. Sci. 16, 342\u2013350", "ArticleIdList": ["22530351"]}, {"Citation": "Hankard R. G., Haymond M. W., and Darmaun D. (1997) Role of glutamine as a glucose precursor in fasting humans. Diabetes 46, 1535\u20131541 10.2337/diabetes.46.10.1535", "ArticleIdList": ["10.2337/diabetes.46.10.1535", "9313746"]}, {"Citation": "Piatti P. M., Monti L. D., Valsecchi G., Magni F., Setola E., Marchesi F., Galli-Kienle M., Pozza G., and Alberti K. G. (2001) Long-term oral l-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 24, 875\u2013880 10.2337/diacare.24.5.875", "ArticleIdList": ["10.2337/diacare.24.5.875", "11347747"]}, {"Citation": "Nair A. B., and Jacob S. (2016) A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7, 27\u201331 10.4103/0976-0105.177703", "ArticleIdList": ["10.4103/0976-0105.177703", "PMC4804402", "27057123"]}, {"Citation": "Dalb\u00f8ge L. S., Almholt D. L., Neerup T. S., Vassiliadis E., Vrang N., Pedersen L., Fosgerau K., and Jelsing J. (2013) Characterisation of age-dependent beta cell dynamics in the male db/db mice. PLoS ONE 8, e82813 10.1371/journal.pone.0082813", "ArticleIdList": ["10.1371/journal.pone.0082813", "PMC3855780", "24324833"]}, {"Citation": "Ahr\u00e9n B., and Scheurink A. J. (1998) Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur. J. Endocrinol. 139, 461\u2013467 10.1530/eje.0.1390461", "ArticleIdList": ["10.1530/eje.0.1390461", "9820626"]}, {"Citation": "Surwit R. S., Feinglos M. N., Rodin J., Sutherland A., Petro A. E., Opara E. C., Kuhn C. M., and Rebuffe-Scrive M. (1995) Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44, 645\u2013651 10.1016/0026-0495(95)90123-X", "ArticleIdList": ["10.1016/0026-0495(95)90123-X", "7752914"]}]}], "History": [{"Year": "2020", "Month": "5", "Day": "15"}, {"Year": "2020", "Month": "6", "Day": "22"}, {"Year": "2020", "Month": "7", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "4"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32605924", "PMC7476719", "10.1074/jbc.RA120.014357", "S0021-9258(17)49975-3"]}}]}